HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vickers, T. A. Articles by Dean, N. M. Search for Related Content PubMed PubMed Citation Articles by Vickers, T. A. Articles by Dean, N. M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH

Modification of MyD88 mRNA Splicing and Inhibition of IL-1 Signaling in Cell Culture and in Mice with a 2'-O-Methoxyethyl-Modified Oligonucleotide

Isis Pharmaceuticals, Department of Functional Genomics, Carlsbad, CA 92008

A number of proinflammatory cytokines, including IL-1, signal through the adaptor protein MyD88. This signaling leads to phosphorylation of IL-1R-associated kinase-1 (IRAK-1) and, ultimately, activation of the NF-B transcription factor. A splice variant of MyD88 (MyD88_S), which lacks the ability to couple IRAK-1 to NF-B, has been described. A chemically modified antisense oligonucleotide (ASO) that alters the splicing ratio of MyD88 to MyD88_S in both cell culture and in animals has been identified. The ASO (ISIS 337846) binds to exon II donor sites in the MyD88 pre-mRNA. By manipulating levels of MyD88 splicing, proinflammatory signaling through the IL-1R has been shown to be diminished, both in cell culture and in mouse liver. To our knowledge, this represents the first example of modulation of RNA splicing of an endogenous gene target in animals after systemic ASO dosing and suggests that this mechanism may be useful as a novel modulator of inflammatory stimuli.

Related articles in The JI:

IN THIS ISSUE

The JI 2006 176: 3289-3290. [Full Text]  

This article has been cited by other articles:

				T. A. Vickers, W. F. Lima, H. Wu, J. G. Nichols, P. S. Linsley, and S. T. Crooke Off-target and a portion of target-specific siRNA mediated mRNA degradation is Ago2 'Slicer' independent and can be mediated by Ago1 Nucleic Acids Res., September 18, 2009; (2009) gkp735v1. [Abstract] [Full Text] [PDF]

				L. G. Fong, T. A. Vickers, E. A. Farber, C. Choi, U. J. Yun, Y. Hu, S. H. Yang, C. Coffinier, R. Lee, L. Yin, et al. Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides Hum. Mol. Genet., July 1, 2009; 18(13): 2462 - 2471. [Abstract] [Full Text] [PDF]

				T. A. Vickers, W. F. Lima, J. G. Nichols, and S. T. Crooke Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells Nucleic Acids Res., October 8, 2007; 35(19): 6598 - 6610. [Abstract] [Full Text] [PDF]

				A. Aartsma-Rus and G.-J. B. van Ommen Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications RNA, October 1, 2007; 13(10): 1609 - 1624. [Abstract] [Full Text] [PDF]

				L. Du, J. M. Pollard, and R. A. Gatti Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides PNAS, April 3, 2007; 104(14): 6007 - 6012. [Abstract] [Full Text] [PDF]